Gene: AMOT
Official Full Name: angiomotinprovided by HGNC
Gene Summary: This gene belongs to the motin family of angiostatin binding proteins characterized by conserved coiled-coil domains and C-terminal PDZ binding motifs. The encoded protein is expressed predominantly in endothelial cells of capillaries as well as larger vessels of the placenta where it may mediate the inhibitory effect of angiostatin on tube formation and the migration of endothelial cells toward growth factors during the formation of new blood vessels. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO08623 | AMOT Knockout cell line (HCT 116) | Human | AMOT | 1:2~1:4 | Negative | Online Inquiry |
KO08624 | AMOT Knockout cell line (HEK293) | Human | AMOT | 1:3~1:6 | Negative | Online Inquiry |
AMOT Gene Knockout Cell Lines are precisely engineered cellular models that have had the AMOT (Angiomotin) gene selectively disrupted, facilitating the investigation of the gene's role in various biological processes. By using CRISPR/Cas9 technology or other gene-editing techniques, these cell lines provide researchers with a reliable platform to study the effects of AMOT deficiency on cellular dynamics, including proliferation, migration, and angiogenesis. The knockout of AMOT allows for an in-depth understanding of its involvement in cellular signaling pathways and its implications in diseases such as cancer, cardiovascular disorders, and developmental abnormalities.
The primary function of AMOT is associated with the regulation of tight junctions and the modulation of cell-cell interactions, making its knockout particularly valuable for studying epithelial-to-mesenchymal transition (EMT) in tumor biology. By employing these cell lines, researchers can elucidate the molecular mechanisms behind tumor metastasis and endothelial cell function, providing insights that are crucial for drug discovery and the development of targeted therapies.
In both research and clinical applications, AMOT Gene Knockout Cell Lines are significant tools for validating potential therapeutic targets and exploring genetic interactions in disease models. These cell lines stand out from conventional models due to their high specificity and the ability to mimic the disease state more closely, allowing for more accurate experimental outcomes.
Moreover, the use of AMOT knockout models in preclinical studies enhances the translational potential of research findings into clinical settings, making them indispensable for drug screening and biomarker discovery. Researchers and clinicians can confidently use these cell lines to obtain relevant and reliable data that could ultimately contribute to novel treatment strategies.
Our company specializes in providing high-quality biological products, and our expertise in gene editing ensures that our AMOT Gene Knockout Cell Lines are produced with precision and rigor, supporting your research endeavors with dependable and valuable resources.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.